cas 1396215-84-1|| where to buy 4,4,5,5-Tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane

Nom du produit:4,4,5,5-Tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane

IUPAC Name:4,4,5,5-tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane

Unité d'emballage	Stock disponible	Prix($)
CM133830-100mg	in stock	Źƥ
CM133830-250mg	in stock	Ɠŗ
CM133830-1g	in stock	ƿǤŹ
CM133830-5g	in stock	ƓȃĲ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1396215-84-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1396215-84-1; Formule moléculaire:C9H17BO3; Point de fusion:-; Code SMILES:CC1(C)C(C)(C)OB(C2COC2)O1; Densité:

: Numéro de catalogue:CM133830; Poids moléculaire:184.04; Point d'ébullition:; N° Mdl:MFCD26521383; Stockage:

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.

: Boronic Acids and Esters; Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).